Search research articles
Contact Us
Filters
Showing results (121-130 of 193) with videos related to
Page
of 20
Sort By:
Haematologica
|
March 7, 2007
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
Simona Soverini, Sabrina Colarossi, Alessandra Gnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients
Ilaria Iacobucci, Giuseppe Saglio, Gianantonio Rosti, et al.
Journal of Clinical Medicine
|
June 5, 2020
Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques
Daniela Cilloni, Jessica Petiti, Valentina Campia, et al.
Blood
|
July 11, 2009
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors
Simona Soverini, Alessandra Gnani, Sabrina Colarossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report
Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.
Cancers
|
November 13, 2021
Droplet Digital PCR for <i>BCR-ABL1</i> Monitoring in Diagnostic Routine: Ready to Start?
Maria Teresa Bochicchio, Jessica Petiti, Paola Berchialla, et al.
American Journal of Hematology
|
June 5, 2025
Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database
Fabio Stagno, Rosalba Cucci, Giovanni Marsili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia
Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.
Haematologica
|
June 11, 2010
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party
Ilaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, et al.
British Journal of Haematology
|
April 12, 2013
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
Guido Finazzi, Alessandro M Vannucchi, Vincenzo Martinelli, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 193) with videos related to
Sort By:
Page
of 20
Haematologica
|
March 7, 2007
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
Simona Soverini, Sabrina Colarossi, Alessandra Gnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients
Ilaria Iacobucci, Giuseppe Saglio, Gianantonio Rosti, et al.
Journal of Clinical Medicine
|
June 5, 2020
Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques
Daniela Cilloni, Jessica Petiti, Valentina Campia, et al.
Blood
|
July 11, 2009
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors
Simona Soverini, Alessandra Gnani, Sabrina Colarossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report
Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.
Cancers
|
November 13, 2021
Droplet Digital PCR for <i>BCR-ABL1</i> Monitoring in Diagnostic Routine: Ready to Start?
Maria Teresa Bochicchio, Jessica Petiti, Paola Berchialla, et al.
American Journal of Hematology
|
June 5, 2025
Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database
Fabio Stagno, Rosalba Cucci, Giovanni Marsili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia
Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.
Haematologica
|
June 11, 2010
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party
Ilaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, et al.
British Journal of Haematology
|
April 12, 2013
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
Guido Finazzi, Alessandro M Vannucchi, Vincenzo Martinelli, et al.
Page
of 20